Back to Journals » Breast Cancer: Targets and Therapy » Volume 14

Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial

Total article views   HTML views PDF downloads Totals
4,048 Dovepress* 3,678+ 181 3,859
PubMed Central* 370 139 509
Totals 4,048 320 4,368
*Since 18 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar